CLINICAL TRIALS PROFILE FOR NATROBA
✉ Email this page to a colleague
All Clinical Trials for natroba
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01660321 ↗ | Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation | Completed | ParaPRO LLC | Phase 4 | 2011-09-01 | A pharmacokinetic and tolerance study of Natroba (spinosad) Topical Suspension, 0.9% in pediatric subjects 6 months to 4 years of age with an active head lice infestation. |
NCT02485704 ↗ | Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies | Completed | Accelovance | Phase 3 | 2017-05-10 | To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the complete cure of scabies after a single treatment. |
NCT02485704 ↗ | Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies | Completed | Concentrics Research | Phase 3 | 2017-05-10 | To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the complete cure of scabies after a single treatment. |
NCT02485704 ↗ | Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies | Completed | ParaPRO LLC | Phase 3 | 2017-05-10 | To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the complete cure of scabies after a single treatment. |
NCT02485717 ↗ | Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies | Completed | Accelovance | Phase 3 | 2017-05-02 | To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the pharmacokinetics (PK) of spinosad and benzyl alcohol following a single dose of Natroba™ in pediatric subjects 4-16 years of age. These subjects will be a separate population of pediatric subjects. |
NCT02485717 ↗ | Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies | Completed | Concentrics Research | Phase 3 | 2017-05-02 | To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the pharmacokinetics (PK) of spinosad and benzyl alcohol following a single dose of Natroba™ in pediatric subjects 4-16 years of age. These subjects will be a separate population of pediatric subjects. |
NCT02485717 ↗ | Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies | Completed | ParaPRO LLC | Phase 3 | 2017-05-02 | To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the pharmacokinetics (PK) of spinosad and benzyl alcohol following a single dose of Natroba™ in pediatric subjects 4-16 years of age. These subjects will be a separate population of pediatric subjects. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for natroba
Condition Name
Clinical Trial Locations for natroba
Trials by Country
Clinical Trial Progress for natroba
Clinical Trial Phase
Clinical Trial Sponsors for natroba
Sponsor Name